Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam dose-finding for procedural sedation during brachial plexus block in adults undergoing upper limb surgery
ChiCTR2300074298Phase 4Not yet recruiting
- Sponsor
- Yan'an University Affiliated Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in procedural sedation and analgesia (PSA), sponsored by Yan'an University Affiliated Hospital. Primary endpoints: Time to satisfied sedation, Severe hypotension and 4 more. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ChiCTR2300074298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074298.